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Abstract  
Obesity involves hypoxic adipose tissue and low-grade chronic inflammation. We 
investigated the impact of hypoxia on inflammatory response to TNF-α in white and 
brown adipocytes. In response to TNF-α, the expression of the inducible enzymes 
iNOS and COX-2 was prominently and selectively potentiated during hypoxia while 
only moderately under normoxia. Levels of their products, nitrite and prostaglandinE2 
were elevated accordingly. NS398, a selective COX-2 inhibitor, reduced nitrite levels. 
The expression of PGC-1α, a transcriptional co-activator involved in mitochondrial 
biogenesis, and PPARγ, a transcription factor involved in adipocyte homeostasis, 
was reduced by TNF-α during hypoxia. These results suggest that hypoxia 
potentiates the inflammatory response by TNF-α in both white and brown adipocytes 
and downregulates the transcription factors involved in adipocyte function. 
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Introduction 
Obesity, which is defined as excessive fat accumulation, is characterized by low-
grade chronic inflammation of adipose tissue [1,2]. The obesity-driven inflammation 
in adipose tissue can progress to other metabolic tissues such as liver, pancreatic 
islets and muscles and mediates insulin-resistance [3]. 
In 1993, Hotamsigil et al., demonstrated that the pro-inflammatory cytokine, tumor 
necrosis factor-α (TNF-α) expression is elevated in adipose tissue of obese rodents 
[4]. Later, macrophages located in the adipose tissue were identified as the source of 
the TNF-α and also of inducible nitric oxide synthase (iNOS) [2]. TNF-α down-
regulates the insulin-sensitive glucose transporter Glut4 in adipocytes [4], and indeed 
both pro-inflammatory proteins TNF-α and inducible nitric oxide synthase (iNOS) 
contribute to the development of obesity-induced insulin resistance in mice [5,6]. 
During normoxia stimulation with TNF-α in several cell lines led to a co-induction of 
iNOS and cyclooxygenase-2 (COX-2) [7,8]. Both iNOS and COX-2 are inducible 
enzymes that generate nitric oxide and prostaglandin, respectively and both act 
cooperatively and synergistically in pathological conditions [9]. In 1993 Salvemini and 
colleagues showed that a cross-talk exists between COX and NOS pathways and 
that NO activates COX enzymes to produce increased amounts of prostaglandins 
[10]. 
The presence of hypoxia in obese adipose tissue and its contribution to the initiation 
and progression of inflammation appears significant [11]. Hypoxia occurs when 
oxygen availability does not match the demand of the surrounding tissue, resulting in 
decreased oxygen tension [12]. In obese adipose tissue, the adipocytes become 
hypertrophied and the diameter of adipocytes increases up to 150 - 200 µm.  Since 
the diffusion limit of oxygen is considered at 100 µm, hence pockets of  hypoxia 
develop within the adipose tissue [11]. Moreover, in obesity vascularization in 
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adipose tissue is compromised which further restricts the oxygen availability to the 
adipocytes [13]. Hypoxia plays an underpinning role in triggering the infiltration of 
macrophages and secretion of pro-inflammatory cytokines such as tumour-necrosis 
factor (TNF), interleukin 6 (IL 6) and, CC-chemokine ligand 2 (CCL2; also known as 
MCP1) [14,15]. Alternatively, inflammation can also drive hypoxia and indeed 
inflammatory disease states are often characterized by tissue hypoxia or stabilization 
of hypoxic markers such as hypoxia-inducible factor (HIF) [16]. Thus, hypoxia and 
inflammation are intertwined at the molecular, cellular, and clinical levels [16] . 
In the present study, using an in-vitro cell culture model of white and brown 
adipocytes, we characterized the effect of hypoxia on the inflammatory response. In 
particular, we investigated the molecules that are perturbed after treatment with TNF-
α during hypoxia. 
 
Materials and methods 
Cell culture and differentiation 
Murine 3T3-L1 preadipocytes (from ATCC, Manassas, VA, USA) at low passage 
were cultured in DMEM growth medium (Biochrom AG, Berlin, Germany) and 
differentiated to adipocytes as done previously [17]. Briefly, 3T3-L1 cells were grown 
to confluence in DMEM with 10% NCS.  The cells were then given the differentiation 
cocktail comprising of 3-isobutyl-1 methylxanthine (0.5 mM), dexamethasone (0.25 
µM), insulin (10 µg/ml) and rosiglitazone (2 µM) in DMEM with 10% FBS. After 3 
days, the media was replaced with DMEM plus 10% FBS and insulin (1 µg/ml). After 
every 2nd day, the media was changed and on 11th day 80-90% of preadipocytes 
were differentiated. The differentiated 3T3-L1 adipocytes were then starved overnight 
in DMEM with FBS (0.5%) and adipocytes were then stimulated with TNF-α (10 
ng/ml) in the presence of normoxia or hypoxia (1% O2) for 24 h.  
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Immortalized preadipocytes (were provided by Prof. Dr. Johannes Klein) when 
differentiated resemble brown adipocytes [18] . The cells were grown in DMEM with 
20% FBS. At 80% confluence, the cells were treated with induction media which 
comprised of T3 (1 nM), indomethacin (0.125 mM), dexamethasone (0.25 µM), 3-
isobutyl-1 methylxanthine (0.5 mM), insulin (10 µg/ml) in DMEM with 20% FBS for 24 
h. Cells were then changed to differentiation media which comprised of DMEM with 
20% FBS, insulin (10 µg/ml) and T3 (1 nM). The differentiation media was changed 
after every 2 days. Differentiation was stopped on the 10th day. Around 80-90% cells 
were differentiated to adipocytes and were starved overnight in DMEM with FBS 
(0.5%). The cells were then stimulated with TNF-α (10 ng/ml) in the presence of 
normoxia or hypoxia (1% O2) for 24 h.  
 
RNA Isolation and Quantitative PCR  
RNA from cells was extracted using RNeasy® lipid tissue kit according to the 
protocol of the manufacturer (Qiagen, Hombrechtikon, Switzerland). RNA quantity 
was determined using Nanodrop 2000 Spectrophotometer. Reverse transcription of 
50 ng RNA was perfomed using iScript™ Reverse Transcription Supermix according 
manufacture’s recommendations (BioRad, Hercules, CA, USA). For quantitative RT-
PCR, final cDNA concentration was adjusted to 10 ng in a 20 µl reaction volume. 
Each reaction was performed in duplicates using Bio-Rad CFX96 Real-Time System 
and iQ™ SYBR® Green Supermix (BioRad, Hercules, CA, USA) using specific 
primers. Gene was normalized to the reference gene acidic ribosomal 
phosphoprotein (Arbp) using the comparative C(T) method [19]. 
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Western Blotting 
Cells were homogenized using the lysis buffer containing Tris.Cl (50 mmol/L, pH 8.0), 
NaCl (150 mM), EDTA (0.5 mM), Triton X-100 (1%), protease inhibitor, and 
phosphatase inhibitor (Sigma, Buchs, Switzerland). Equal amounts of protein were 
loaded for SDS-PAGE, transferred to nitrocellulose and analyzed with the indicated 
antibodies. Immunoblotting was performed using the antibodies against iNOS, ERK2 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), COX-2 and COX-1 (Cayman 
Chemical Company, Ann Arbor, Michigan USA). The membranes were then 
incubated with the corresponding HRP-conjugated secondary antibodies (GE 
Healthcare, Buckinghamshire, UK). Labeled proteins were visualized on X-ray films 
using a chemiluminescence reaction. 
 
Immunoprecipitation  
3T3-L1 adipocytes were lysed with Tris.Cl (100 mmol/L, pH 7.4), NaCl (150 mM), 
glycerol (10%), Triton X-100 (1%), protease inhibitor, and phosphatase inhibitor 
(Sigma, Buchs, Switzerland). The co-immunoprecipitation was performed as 
mentioned before [20]. Briefly, 800 µl of lysis supernatant was pre-cleaned for non-
specific binding by incubating with 50 µl protein A-Sepharose. After a quick spin, the 
supernatant was pipetted into a new eppendorf tube and incubated for overnight with 
COX-2 antibody at 4°C on a rotator. Subsequently, 80 µl of Protein A-Sepharose 
beads were added for 2 h under rotation at 4°C. The pellet was washed 3 times with 
lysis buffer and was boiled in SDS sample buffer and loaded to an 8% SDS PAGE. 
Immunoblotting was performed using iNOS antibody.  The membranes were then 
incubated with the corresponding HRP-conjugated secondary antibodies (GE 
Healthcare, Buckinghamshire, UK). Labeled proteins were visualized on X-ray films 
using a chemiluminescence reaction. 
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Measurement of nitrite 
Adipocytes kept in normoxia or hypoxia incubators were treated with or without TNF-
α (10 ng/ml) for 24 h. The cells were pre-treated either with iNOS specific inhibitor 
1400W (10 µM; Cayman chemical) or COX-2 specific inhibitor NS398 (10µM; Enzo 
Life Sciences, Lausen, Switzerland). The culture supernatants were collected to 
measure the released nitric oxide (NO). Levels of NO, in form of nitrite (NO2
-) were 
determined using Griess reagent (1% sulfanilamide, 0.1% N-1-naphthylenediamine 
dihydrochloride, and 2.5% phosphoric acid) as done previously [21]. The absorbance 
was measured at 570 nm with a multi-mode microplate reader (Molecular Devices, 
Spectra Max M2, Bucher Biotec, Basel, Switzerland). 
 
Determination of PGE2 production 
PGE2 was measured in the culture media by competitive enzyme immunoassay 
according to the manufacturer’s protocol (Cayman Chemical Co., Ann Arbor, MI, 
USA). Briefly, cells in normoxia or hypoxia were pre-treated either with 1400W (10 
µM) or NS398 (10 µM) along with or without TNF-α (10 ng/ml) for 24 h. The cell 
culture medium was collected and centrifuged at 500 g for 5 min. The supernatant 
was used to measure the prostaglandinE2 (PGE2) levels. 
 
Statistical analysis 
Student’s t test was used to compare data between two groups. Values are 
expressed as means ± SEM of three independent experiments. P < 0.05 was 
considered statistically significant. 
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Results 
TNF-α increases the expression of iNos and Cox-2 in hypoxic adipocytes  
Around 80% of 3T3-L1 preadipocytes were differentiated to adipocytes (Fig. 1A). In 
3T3-L1 preadipocytes, stimulation with TNF-α increased the gene expression of iNos 
in normoxia and to a greater extent in hypoxia; however they were non-significant 
(Fig 1B). The gene expression of Cox-2 was minutely increased with TNF-α and the 
increase was similar between normoxic and hypoxic conditions (Fig. 1B). When 
differentiated 3T3-L1 adipocytes were used, stimulation with TNF-α increased the 
gene expression of iNos in normoxia and its expression was increased by 7-fold in 
hypoxia (Fig. 1C). The Cox-2 gene expression was also increased by 7-fold in 
adipocytes treated with TNF-α in the presence of hypoxia compared with normoxia 
(Fig. 1C). When brown adipocytes were used, treatment with TNF-α increased the 
expression of iNos gene and its expression was around 40-fold higher in hypoxia as 
compared with normoxia (Fig. 1D). The expression of Cox-2 gene in the presence of 
TNF-α and hypoxia was increased in brown adipocytes but was not significant 
compared with normoxia (Fig. 1D). 
3T3-L1 adipocytes treated with TNF-α increased the protein expression of iNOS in 
normoxia. Adipocytes in hypoxia treated with TNF-α caused a robust increase in the 
protein expression of iNOS and COX-2 (Fig. 1E) but not of COX-1 (data not shown). 
A significant increase in expression of iNOS and COX-2 was also observed in brown 
adipocytes under hypoxia and TNF-α (Fig. 1F). Stimulation of 3T3-L1 preadipocytes 
with TNF-α in the presence of hypoxia did not increase the expression of iNOS and 
COX-2 (Fig. 1G). Similarly, in endothelial cells iNOS and COX-2 protein expression 
was not increased by hypoxia and TNF-α (Fig. 1H). 
Since iNOS and COX-2 is co-induced in adipocytes in the presence of hypoxia and 
TNF-α, an immunoprecipitation experiment was performed to determine whether 
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iNOS physically interacts with COX-2 (Supplementary Figure 1). The data suggest 
that in endogenous condition, iNOS does not bind to COX-2 in adipocytes. 
 
TNF-α alters the gene expression of cytokines in normoxia and hypoxia  
In 3T3-L1 adipocytes, the gene expression of pro-inflammatory genes such as 
interleukin 6 (IL 6), serum amyloid A1 (SAA1), regulated on activation, normal T cell 
expressed and secreted (Rantes) and monocyte chemoattractant protein1 (MCP1) 
was similarly increased after stimulation with TNF-α in normoxic and hypoxic 
conditions (Fig. 2). In contrast, the gene expression of anti-inflammatory adiponectin 
and leptin was decreased in the presence of TNF-α in normoxia and to a same extent 
by hypoxia. Hypoxia alone increased the gene expression of plasminogen activator 
inhibitor type 1(PAI-1) by 3-fold and the expression levels were similar when cells 
were treated with TNF-α in hypoxia (Supplementary Figure 2A). The gene expression 
of vascular endothelial growth factor (VEGF), a pro-angiogenic molecule, was 
increased only by hypoxia and TNF-α had no effect on its expression (Supplementary 
Figure 2B). 
 
iNOS and COX-2 inhibitors reduce nitrite levels 
Since iNOS was significantly increased in adipocytes by TNF-α during hypoxia, the 
nitrite levels were measured in 3T3-L1 adipocytes under these conditions. As 
compared with only hypoxia, the nitrite levels were not significantly increased in 
presence of hypoxia with TNF-α (Fig. 3A). The increased nitrite levels in hypoxia 
were significantly reduced by iNOS specific inhibitor 1400W (Fig. 3A). Interestingly, 
the COX-2 specific inhibitor NS398 also reduced the nitrite level (Fig. 3B).  
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TNF-α and hypoxia increases PGE2 levels  
The expression of COX-2 was significantly upregulated by TNF-α during hypoxia, 
hence the functional activity of COX-2 was evaluated and its enzymatic product PGE2 
was measured in similar conditions. Treatment of adipocytes with TNF-α in the 
presence of hypoxia significantly increased the levels of PGE2. In the presence of 
iNOS specific inhibitor, 1400W, the PGE2 levels were not significantly reduced (Fig. 
3C). In contrast, the selective COX-2 inhibitor, NS398, significantly reduced the 
increased levels of PGE2 in hypoxia (Fig. 3D).   
 
TNF-α and hypoxia decreases PGC-1α mRNA 
We then investigated the gene expression of some pro-inflammatory transcription 
factors and its co-activators. ATF3, a pro-inflammatory transcription factor was 
increased by TNF-α in the presence of normoxia (Fig. 4A). Hypoxia alone or together 
with TNF-α increased the gene expression of ATF3 and the expression levels were 
similar. The gene expression of PPARγ, a transcription factor required for adipocyte 
homeostasis, was reduced by 2-fold upon TNF-α treatment in the presence of 
normoxia and was further reduced, albeit non-significantly, with hypoxia (Fig. 4B). 
Nrf-1, a transcription factor involved in mitochondrial biogenesis, was reduced by 1.6-
fold with TNF-α in the presence of normoxia and to the same extent by hypoxia (Fig. 
4C). The gene expression of PGC-1α, a co-activator of transcription factor which is 
also involved in mitochondrial biogenesis, was reduced by 4-fold after treatment with 
TNF-α in the presence of normoxia (Fig. 4D). Hypoxic condition reduced the gene 
expression of PGC-1α to the same extent. Interestingly, treatment of adipocytes with 
TNF-α during hypoxia further decreased the expression of PGC-1α (by 3-fold) in 
comparison with normoxia and TNF-α. 
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Discussion 
Development of adverse pathophysiological conditions in obesity involves 
inflammation [3,22]. Heightened levels of TNF-α in obese individuals triggers 
adipocyte dysfunction [23] and mediates insulin resistance [4,22,24]. Macrophages 
within the adipose tissue are supposedly the source of TNF-α [2]. In this study, we 
mimicked the pro-inflammatory environment in adipose tissue by stimulating 
adipocytes under normoxia and hypoxia with exogenous TNF-α. In both normoxic 
and hypoxic conditions, TNF-α increased the expression of several pro-inflammatory 
and acute-phase molecules such as IL-6, SAA, Rantes, MCP-1, PAI-1 and reduced 
the expression of cytokines such as adiponectin and leptin. Furthermore, TNF-α 
stimulated the expression of iNOS and COX-2 in normoxia and interestingly, hypoxia 
potentiated the effect of TNF-α in inducing iNOS and COX-2 expression in both white 
and brown adipocytes. 
It is well established that hypoxia in obese adipose tissue triggers inflammation and 
pockets of hypoxia colocalize with the presence of macrophages [11,15,25]. The 
robust increase in the expression of iNOS and COX-2 after TNF-α stimulation during 
hypoxia was observed specifically in adipocytes (white and brown) and not in 
preadipocytes and endothelial cells. Cardiomyocytes treated with IL-1β in the 
presence of hypoxia reduced the expression of iNOS and displayed reduced levels of 
nitrite [26]. This suggests that inflammatory stimuli and hypoxia driven induction of 
iNOS and COX-2 is evident in adipocytes and is clearly cell type dependent. A 
crosstalk between iNOS and COX-2 has been reported and a physical interaction 
between the molecules was shown using an overexpression system in HEK293T 
cells [20]. However, in our work, we could not detect a physical interaction under 
endogenous setting even with high expression levels of iNOS and COX-2. Murine 
macrophages stimulated with IFN-γ increased the expression of iNOS mRNA 
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however nitrite did not accumulate in culture supernatant [27]. In our experiments, 
hypoxia caused a significant rise in nitrite level even with low iNOS expression. 
However, hypoxia plus TNF-α did not significantly augment the nitrite levels further 
even with elevated iNOS expression levels. Since oxygenation is critical for nitric 
oxide formation and it has been suggested that oxygenation mediates the 
accumulation of nitrite in culture supernatant [27]. It is thus possible that the 
conserved release of nitrite in presence of hypoxia and TNF-α was due to the 
absence of re-oxygenation in our experimental setting. The inhibitor studies using 
iNOS selective inhibitor, 1400W, indicate that the iNOS was involved in nitric oxide 
release in hypoxia. Surprisingly, the levels of nitrite were lowered when COX-2 
specific inhibitor NS398 was used. The COX-2 product prostaglandin E2 was only 
lowered by NS398 and not by 1400W. These findings suggest that in differentiated 
adipocytes COX-2 may be upstream of iNOS in the signalling cascade.  
Decreased mitochondrial biogenesis increases iNOS expression in adipocytes [28] 
and PGC-1α, a transcriptional coactivator, is important for mitochondrial biogenesis 
[29]. Chronic exposure of adipocytes to TNF-α under normoxia causes insulin 
resistance and decreases PGC-1α expression [24]. In our study, the expression of 
PGC-1α was significantly lowered after adipocytes were exposed to hypoxia in the 
presence of TNF-α. In white adipose tissue, PGC-1α stimulates its own transcription 
by coactivating the transcription factor PPARγ [30]. In our study, the expression of 
PPARγ was also decreased by hypoxia in the presence of TNF-α. Thus, the lower 
expression of PPARγ could be the linked to the low PGC-1α expression.  It has been 
shown that mice with iNOS deletion in brown adipose tissue have an enhanced 
expression of PGC-1α [31].  This can be extrapolated to our finding and suggest a 
probable link between the expression of iNOS and PGC-1α. Moreover, leptin 
increases PGC-1α expression [32]. In our study, expression of leptin was decreased 
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after adipocytes were exposed to hypoxia with TNF-α. In adipocytes, the 
mitochondrial function is essential for adiponectin synthesis [33]. The low expression 
of adiponectin in our study indicates the presence of mitochondrial dysfunction by 
hypoxia and TNF-α.  Thus, the increased expression of iNOS and COX-2 along with 
decreased expression of adiponectin, leptin, PPARγ and PGC-1α contribute to 
adipocyte dysfunction probably via altering the mitochondrial function. 
At a pathophysiological level the in vitro findings in this work suggest that hypoxia 
within adipose depots in obese patients could further worsen an existent low-level 
inflammation by amplifying the inflammatory response. Therefore, methods to reduce 
hypoxia within obese adipose tissue may be of importance. In this regard, improving 
vascularization and thus oxygenation using anti-hypertensive drugs such as 
angiotensin-converting enzyme inhibitors which normalize rarefied microvessel 
density [34] could be an useful approach. Moreover, practicing healthy lifestyle can 
promote oxygenation and reduce the tissue inflammatory load. Thus, the reduction in 
hypoxia-mediated inflammation and lowering of iNOS and COX-2 expression in 
adipose tissue could prevent or even reverse the worsening of obesity-associated 
pathophysiological conditions. 
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Figure Legends 
Fig. 1: Gene and protein Expression of iNos and Cox-2. (A) Differentiation of 3T3-
L1 preadipocytes to adipocytes. (B) 3T3-L1 preadipocytes, (C) 3T3-L1 adipocytes 
and (D) brown adipocytes were stimulated without or with TNF-α for 24 h in the 
presence of normoxia (21% O2) or hypoxia (1% O2). Gene expression of iNos and 
Cox-2 were examined using real time qPCR. *p<0.05 vs. normoxia and TNF-α. N=3-
5. (E) Cell lysates from 3T3-L1 adipocytes, (F) brown adipocytes, (G) 3T3-L1 
preadipocytes and (H) mouse aortic endothelial cells were immunoblotted with 
specific iNOS or COX-2 antibodies. The protein loading was checked using Erk2 
antibody. N=3. 
 
Fig. 2: Gene expression of cytokines. 3T3-L1 adipocytes were stimulated without 
or with TNF-α for 24 h in the presence of normoxia (21% O2) or hypoxia (1% O2). 
Gene expression was examined using real time qPCR. N=3-4. 
 
Fig. 3: Measurement of nitrite and prostaglandin E2.  The levels of nitrite were 
measured in the conditioned media using Griess reagent. (A) The 3T3-L1 adipocytes 
in hypoxia were pre-treated either with 1400W or (B) with NS398 in the presence or 
absence of TNF-α for 24 h. *p<0.05 vs. hypoxia. N=3. 
The levels of prostaglandin E2 (PGE2) were measured from the conditioned media. 
(C) The 3T3-L1 adipocytes in hypoxia were pre-treated either with 1400W or with (D) 
NS398 in the presence or absence of TNF-α for 24 h. *p<0.05 vs. hypoxia. N=3. 
 
Fig. 4: Gene expression of transcription factors or its co-activators. 3T3-L1 
adipocytes were stimulated without or with TNF-α for 24 h in the presence of 
normoxia (21% O2) or hypoxia (1% O2). (A) Gene expression of ATF3, (B) PPARγ, 
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(C) Nrf-1 and (D) PGC-1α were examined using real time qPCR. *p<0.05 vs. 
normoxia with TNF-α. N=4-6. 
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